They're pushing for more funding to find effective treatments. Researchers are finally starting to make headway but have a ...
Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...
A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in ...
HIV is not like TB. While TB treatment takes six long months, this is a curable disease. HIV, on the other hand, cannot be ...
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...